Short answer

Consider the impact of specific biological markers on human physiological states when designing health-related products or systems.

Field: Human Factors
Source: Scientific Reports (2024)
Method: Meta-analysis of observational studies
Sample: 27,459 individuals
Evidence: Strong effect

Elevated levels of Fibroblast Growth Factor 23 (FGF-23) are associated with increased arterial calcification, thickness, and stiffness, while higher Klotho levels are linked to reduced arterial calcification and thickness. This human factors research insight is drawn from a 2024 study published in Scientific Reports. Using Meta-analysis of observational studies with 27,459 individuals, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Consider the impact of specific biological markers on human physiological states when designing health-related products or systems.

Study

Human FactorsRecentStrong effect

Biomarkers FGF-23 and Klotho Influence Arterial Health Metrics

Scientific Reports · 2024

Key Findings

01FGF-23 was positively correlated with arterial calcification (r = 0.446), CIMT (r = 0.188), and PWV (r = 0.235).
02Klotho was inversely correlated with arterial calcification (r = -0.388) and CIMT (r = -0.38).

Application

Design takeaway

Consider the impact of specific biological markers on human physiological states when designing health-related products or systems.

How to apply

When designing health-related technologies or interventions, consider how they might interact with or be influenced by known physiological markers of disease progression.

Project actions

01When researching a design problem, look for existing scientific studies that identify key biological or physiological factors influencing the user's condition.
02Consider how your design might indirectly or directly impact these identified factors.

Method & Evidence

AimTo determine the association between Klotho and Fibroblast Growth Factor 23 (FGF-23) levels and arterial calcification, thickness, and stiffness in humans.

MethodMeta-analysis of observational studies

ProcedureA systematic literature search was performed across five databases to identify observational studies investigating the role of Klotho and FGF-23 in arterial remodeling. Data on arterial calcification, thickness (measured by carotid intima-media thickness - CIMT), and stiffness (measured by pulse wave velocity - PWV) were extracted and analyzed. Correlations were calculated using meta-analysis techniques.

Sample27,459 individuals

ContextCardiovascular health, internal medicine, cardiology, chronic kidney disease

Variables

IV["Levels of Fibroblast Growth Factor 23 (FGF-23)","Levels of Klotho"]

DV["Arterial calcification","Arterial thickness (Carotid Intima-Media Thickness - CIMT)","Arterial stiffness (Pulse Wave Velocity - PWV)"]

CV["Study design (e.g., cross-sectional, cohort)","Measurement methods for arterial parameters","Participant characteristics (e.g., age, sex, comorbidities, though these are aggregated in a meta-analysis)"]

Strengths & Limitations

Strengths

+Large sample size due to meta-analysis.
+Systematic approach to literature review and data synthesis.

Limitations

The study is a meta-analysis of observational data, meaning it can show associations but not prove cause and effect. The findings are strongest in people with kidney disease.

Reliability & validity

The reliability of the findings is strengthened by the meta-analysis approach, which aggregates data from multiple studies. Validity is supported by the use of established measurement methods for arterial calcification, thickness, and stiffness. However, the reliance on observational studies limits causal validity.

Think critically

Given that this study primarily focused on individuals with chronic kidney disease, how might the observed associations between FGF-23, Klotho, and arterial health differ in a general, healthy population?

Design Principles

"Design for physiological well-being by understanding and accounting for key biological indicators of health."

Understanding the relationship between these biomarkers and arterial health provides crucial insights for designing interventions and diagnostic tools. This knowledge can inform the development of strategies to mitigate cardiovascular risks, particularly in populations with chronic kidney disease.

What This Means for Your Design

This study looked at two substances in the body, FGF-23 and Klotho, and how they relate to the hardening and thickening of arteries. It found that more FGF-23 means arteries are more likely to be calcified and stiff, while more Klotho means they are less likely to be calcified and thick.

How to use in your project

1.Reference this study to support claims about the physiological factors that influence the user's condition and how your design aims to address them.

Add to My Project

Quick Cite

Paragraph starter

Research indicates that specific biomarkers, such as Fibroblast Growth Factor 23 (FGF-23) and Klotho, play a significant role in arterial remodeling processes, influencing arterial calcification, thickness, and stiffness. Elevated FGF-23 levels are associated with increased arterial calcification and stiffness, while higher Klotho levels are linked to reduced calcification and thickness. This understanding is crucial for designing interventions that target cardiovascular health.

Source

Scientific Reports

Role of klotho and fibroblast growth factor 23 in arterial calcification, thickness, and stiffness: a meta-analysis of observational studies

journal · 2024

View source

Questions About This Research

What does the research say about biomarkers fgf-23 and klotho influence arterial health metrics?: Consider the impact of specific biological markers on human physiological states when designing health-related products or systems. Evidence: Scientific Reports (2024).
Why does "Biomarkers FGF-23 and Klotho Influence Arterial Health Metrics" matter for design?: Understanding the relationship between these biomarkers and arterial health provides crucial insights for designing interventions and diagnostic tools. This knowledge can inform the development of strategies to mitigate cardiovascular risks, particularly in populations with chronic kidney disease.
How can designers apply this research?: Consider the impact of specific biological markers on human physiological states when designing health-related products or systems.
What were the main findings?: FGF-23 was positively correlated with arterial calcification (r = 0.446), CIMT (r = 0.188), and PWV (r = 0.235).. Klotho was inversely correlated with arterial calcification (r = -0.388) and CIMT (r = -0.38).
What research method was used?: Meta-analysis of observational studies with 27,459 individuals.
How strong is the evidence?: Evidence strength is rated Strong effect, based on a 2024 journal from Scientific Reports.
What should I do differently in my next project?: When designing health-related technologies or interventions, consider how they might interact with or be influenced by known physiological markers of disease progression.
What are the limitations?: Most included studies were cross-sectional, limiting the ability to establish causality. The primary population studied was patients with chronic kidney disease, which may limit generalizability to the broader population.